{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:32:28Z","timestamp":1768285948872,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.prp.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T14:16:47Z","timestamp":1468678607000},"page":"876-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions"],"prefix":"10.1016","volume":"212","author":[{"given":"Tina","family":"Shooshtarizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-7394","authenticated-orcid":false,"given":"Sajjadeh","family":"Movahedinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2016.07.007_bib0005","series-title":"Bone and Soft Tissue Pathology","author":"Folpe","year":"2010"},{"issue":"2","key":"10.1016\/j.prp.2016.07.007_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0019-5413.77138","article-title":"Local recurrences after curettage and cementing in long bone giant cell tumor","volume":"45","author":"Saikia","year":"2011","journal-title":"Indian J. Orthop."},{"key":"10.1016\/j.prp.2016.07.007_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1746-1596-5-62","article-title":"A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases","volume":"5","author":"Miller","year":"2010","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2016.07.007_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.coc.0000195089.11620.b7","article-title":"Giant cell tumor of bone","volume":"29","author":"Mendenhall","year":"2006","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2016.07.007_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/rg.311105048","article-title":"Best cases from the AFIP: necrotic giant cell tumor of bone manifesting with pathologic fracture","volume":"31","author":"Arnold","year":"2011","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.prp.2016.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1148\/radiographics.21.5.g01se251283","article-title":"From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation","volume":"21","author":"Murphey","year":"2001","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.prp.2016.07.007_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ocl.2005.08.005","article-title":"Giant cell tumor of bone","volume":"37","author":"Turcotte","year":"2006","journal-title":"Orthop. Clin. North Am."},{"issue":"397","key":"10.1016\/j.prp.2016.07.007_bib0040","first-page":"248","article-title":"Giant cell tumor of long bone: a Canadian Sarcoma Group study","volume":"2002","author":"Turcotte","year":"2016","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"9","key":"10.1016\/j.prp.2016.07.007_bib0045","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","article-title":"Giant cell tumor of bone: treatment and outcome of 214 cases","volume":"134","author":"Balke","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.07.007_bib0050","volume":"vol. 4","author":"Brant","year":"2012"},{"issue":"4","key":"10.1016\/j.prp.2016.07.007_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/modpathol.2008.29","article-title":"Giant cell tumor of bone express p63","volume":"21","author":"Dickson","year":"2008","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2016.07.007_bib0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.5858\/2010-0291-OA.1","article-title":"p63 expression in giant cell-containing lesions of bone and soft tissue","volume":"135","author":"de la Roza","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2016.07.007_bib0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1746-1596-7-130","article-title":"Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience","volume":"7","author":"Hammas","year":"2012","journal-title":"Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2016.07.007_bib0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3892\/ijo.2012.1727","article-title":"p63 Regulates cell proliferation and cell cycle progressionassociated genes in stromal cells of giant cell tumor of the bone","volume":"42","author":"Lau","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2016.07.007_bib0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.3801023","article-title":"Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone","volume":"21","author":"Lee","year":"2008","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2016.07.007_bib0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-014-1637-z","article-title":"A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50% of cells is stained","volume":"465","author":"Maues De Paula","year":"2014","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.prp.2016.07.007_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/03009734.2012.724731","article-title":"p63 as a prognostic marker for giant cell tumor of bone","volume":"118","author":"Yanagisawa","year":"2013","journal-title":"Ups. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.prp.2016.07.007_bib0090","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0092-8674(00)80540-1","article-title":"Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers","volume":"90","author":"Kaghad","year":"1997","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.prp.2016.07.007_bib0095","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/cdd.2011.81","article-title":"p63 Is a suppressor of tumorigenesis and metastasis interacting with mutant p53","volume":"18","author":"Melino","year":"2011","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.prp.2016.07.007_bib0100","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/MCB.23.7.2264-2276.2003","article-title":"The delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations","volume":"23","author":"Westfall","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.prp.2016.07.007_bib0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","article-title":"p63, a p53 Homolog at 3q27\u201329, encodes multiple products with transactivating, death-inducing, and dominant-negative activities","volume":"2","author":"Yang","year":"1998","journal-title":"Mol. Cell"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816302515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816302515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T05:05:32Z","timestamp":1656824732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816302515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0344033816302515"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.07.007","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}